Cargando…
The Impact of the COVID-19 Pandemic on Exacerbations and Symptoms in Bronchiectasis: A Prospective Study
Autores principales: | Crichton, Megan L., Shoemark, Amelia, Chalmers, James D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528525/ https://www.ncbi.nlm.nih.gov/pubmed/34265234 http://dx.doi.org/10.1164/rccm.202105-1137LE |
Ejemplares similares
-
Development and initial validation of the bronchiectasis exacerbation and symptom tool (BEST)
por: Artaraz, Amaia, et al.
Publicado: (2020) -
Pulmonary rehabilitation after exacerbation of bronchiectasis: a pilot randomized controlled trial
por: Chalmers, James D., et al.
Publicado: (2019) -
Adrenal reserve in acute exacerbation of non-cystic fibrosis bronchiectasis
por: Rajagopala, Srinivas, et al.
Publicado: (2015) -
A systematic review of pharmacotherapeutic clinical trial end-points for bronchiectasis in adults
por: Crichton, Megan L., et al.
Publicado: (2019) -
“The missing ingredient”: the patient perspective of health related quality of life in bronchiectasis: a qualitative study
por: Dudgeon, Emily K., et al.
Publicado: (2018)